Ali Lourhmati Selected Research

Ali Lourhmati Research Topics

3	Alzheimer Disease (Alzheimer's Disease) 02/2021 - 01/2019
3	Hypoxia (Hypoxemia) 12/2017 - 09/2007
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 02/2011
2	Neuroinflammatory Diseases 01/2019 - 12/2017
1	Memory Disorders (Memory Loss) 02/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Stroke (Strokes) 01/2019
1	Huntington Disease (Huntington's Disease) 01/2019
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2014
1	Neoplasms (Cancer) 01/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2014
1	Hyperammonemia 01/2009
1	Pathologic Processes 01/2009

3	Amyloid beta-PeptidesIBA 02/2021 - 12/2017
2	Angiotensin Receptor AntagonistsIBA 02/2021 - 01/2019
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2019 - 09/2007
2	Glutamic Acid (Glutamate)FDA Link 12/2017 - 01/2013
1	Cholinergic Agents (Cholinergics)IBA 02/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Losartan (Cozaar)FDA LinkGeneric 01/2019
1	Insulysin (Insulin-Degrading Enzyme)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Prealbumin (Transthyretin)IBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2017
1	Amyloid (Amyloid Fibrils)IBA 12/2017
1	mesedinIBA 12/2017
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2014
1	Erythropoietin FDA Link 01/2013
1	Glutamine (L-Glutamine)FDA Link 01/2009
1	EnzymesIBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007